Randomized controlled trials in surgical oncology: where do we stand? (original) (raw)
Abstract
This article reviews the history of clinical trials in surgery using breast cancer surgery and rectal cancer surgery as examples. Trials in breast cancer have transformed the surgical management of this disease. Rectal cancer surgery has also changed greatly, but much of this evolution occurred outside the setting of clinical trials. This article highlights the strengths and limitations of surgical trials and suggests that future studies should include pretrial credentialing as a requirement for surgeon participation. More work needs to be done to bridge the gap from trial results to implementation of new techniques in clinical practice.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
References (84)
- Howes N, Chagla L, Thorpe M, et al. Surgical practice is evidence based. Br J Surg 1997;84(9):1220-3.
- Halsted W. The results of operations for cure of cancer of the breast performed at the John Hopkins Hospital from June 1889 to January 1894. Ann Surg 1894;20(5): 297-350.
- Fentiman I. Long-term follow-up of the first breast conservation trial: Guy' wide excision study. Breast 2000;9(1):5-8.
- Veronesi U, Saccozzi R, Vecchio MD, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305(1):6-11.
- Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 1995;31A(10):1574-9.
- Veronisi U. Conservative treatment of breast cancer: a trial in progress at the Cancer Institute of Milan. World J Surg 1977;1(3):324-6.
- Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radia- tion. N Engl J Med 1985;312(11):674-81.
- Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy fol- lowed by irradiation. N Engl J Med 2002;347(8):567-75.
- Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
- Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpec- tomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328(22):1581-6.
- Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347(16):1233-41.
- Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radi- ation in the treatment of breast cancer. N Engl J Med 1985;312(11):665-73.
- Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320(13):822-8.
- Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lump- ectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333(22):1456-61.
- Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer 1977;39(Suppl 6):2827-39.
- Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17(8):2326-33.
- Renton SC, Gazet JC, Ford HT, et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 1996;22(1):17-22.
- Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996;88(22): 1659-64.
- Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conser- vation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996;348(9029):708-13.
- Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12(7):997-1003.
- Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20(20):4141-9.
- Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irra- diation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351(10):963-70.
- Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351(10):971-7.
- Fisher B, Dignam J, Wolmark N, et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 1997;89(22):1673-82.
- Arriagada R, Spielmann M, Koscielny S, et al. Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen. Ann Oncol 2002;13(9):1378-86.
- Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph- node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8(10):881-8.
- Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 rand- omised phase 3 trial. Lancet Oncol 2010;11(10):927-33.
- Zavagno G, De Salvo GL, Scalco G, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008;247(2):207-13.
- Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg On- col 2010;102(2):111-8.
- Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98(9):599-609.
- Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7(12):983-90.
- Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305(6):569-75.
- Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16(8):2672-85.
- Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project protocols B-18 and B-27. J Clin Oncol 2008;26(5):778-85.
- Ellis MJ, Suman VJ, Hoog J, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype- ACOSOG Z1031. J Clin Oncol 2011;29(17):2342-9.
- Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen- treated, node-negative breast cancer. N Engl J Med 2004;351(27):2817-26.
- Miles W. A method of performing abdominoperineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon. Lancet 1908;2:1812-3.
- Dixon CF. Anterior resection for malignant lesions of the upper part of the rectum and lower part of the sigmoid. Ann Surg 1948;128(3):425-42.
- Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg 1983;70(3):150-4.
- Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80(1):21-9.
- Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet 1996;348(9042):1610-4.
- Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92(5):388-96.
- Bentzen SM, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992;65(1):102-7.
- Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985;312(23):1465-72.
- Douglass HO Jr, Moertel CG, Mayer RJ, et al. Survival after postoperative combi- nation treatment of rectal cancer. N Engl J Med 1986;315(20):1294-5.
- Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358(9290):1291-304.
- Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324(11):709-15.
- Adjuvant therapy for patients with colon and rectum cancer. Consens Statement 1990;8(4):1-25.
- Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treat- ment in rectal cancer. Final results of a randomized study of the European Organiza- tion for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208(5):606-14.
- Cedermark B, Johansson H, Rutqvist LE, et al. The Stockholm I trial of preoper- ative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75(9):2269-75.
- Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group. Ann Surg Oncol 1996;3(5):423-30.
- Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23(24):5644-50.
- Birgisson H, Pahlman L, Gunnarsson U, et al. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008;95(2):206-13.
- Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373(9666):811-20.
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative che- moradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-40.
- Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27(31):5124-30.
- Dahl O, Horn A, Morild I, et al. Low-dose preoperative radiation postpones recur- rences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer 1990;66(11):2286-94.
- Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000;284(8):1008-15.
- Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638-46.
- Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow- up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246(5):693-701.
- van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12(6):575-82.
- Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radio- therapy in rectal cancer. N Engl J Med 2006;355(11):1114-23.
- Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preop- erative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93(10):1215-23.
- Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24(28):4620-5.
- Latkauskas T, Paskauskas S, Dambrauskas Z, et al. Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis. Colorectal Dis 2010;12(11):1075-83.
- Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Ann Oncol 2010;21(9):1743-50.
- Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93(8):583-96.
- Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010;97(11):1638-45.
- Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365(9472):1718-26.
- Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007;25(21):3061-8.
- Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparo- scopic and open surgery in patients with rectal cancer. Br J Surg 2009;96(9):982-9.
- Lezoche G, Baldarelli M, Guerrieri M, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 2008;22(2):352-8.
- Winde G, Nottberg H, Keller R, et al. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996;39(9):969-76.
- Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg 2002;236(4):522-9 [discussion: 529-30].
- Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000;43(8):1064-71 [discussion: 1071-4].
- You YN, Baxter NN, Stewart A, et al. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg 2007;245(5):726-33.
- Sachdeva AK, Russell TR. Safe introduction of new procedures and emerging technologies in surgery: education, credentialing, and privileging. Surg Clin North Am 2007;87(4):853-66, vi-vii.
- Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multi- center validation study. N Engl J Med 1998;339(14):941-6.
- Tafra L, McMasters KM, Whitworth P, et al. Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 2000;180(4):268-73.
- McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234(3):292-9 [discussion: 299-300].
- Harlow SP, Krag DN, Julian TB, et al. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005;241(1):48-54.
- Barker AD, Sigman CC, Kelloff GJ, et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009; 86(1):97-100.
- American College of Surgeons accredited education institutes. 2011. Available at: http://www.facs.org/education/accreditationprogram/. Accessed November 2, 2011.
- Merkow RP, Ko CY. Evidence-based medicine in surgery: the importance of both experimental and observational study designs. JAMA 2011;306(4):436-7.